Evolent Health, Inc. (EVH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Remitly Global, Inc.

Progyny, Inc.

Grand Canyon Education, Inc.

MAXIMUS, Inc.

ADT, Inc.

The Brink's Co.

Concentrix Corp.

Bright Horizons Family Solutions, Inc.

Clarivate Plc

Shift4 Payments, Inc.

Evolent Health, Inc.

Why is Evolent Health, Inc. ?

Poor Management Efficiency with a low ROCE of 0.44%

The company has been able to generate a Return on Capital Employed (avg) of 0.44% signifying low profitability per unit of total capital (equity and debt)

The company has declared negative results for the last 3 consecutive quarters

PRE-TAX PROFIT(Q) At USD -7.73 MM has Fallen at -355.12%
NET PROFIT(Q) At USD -6.9 MM has Fallen at -311.27%
OPERATING CASH FLOW(Y) Lowest at USD -33.32 MM

Risky - Negative Operating Profits

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -67.03%, its profits have fallen by -7350%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -67.03% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Evolent Health, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Evolent Health, Inc.

-76.55%

-1.23

67.61%

S&P 500

13.68%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.79%

EBIT Growth (5y)

16.15%

EBIT to Interest (avg)

-0.03

Debt to EBITDA (avg)

3.44

Net Debt to Equity (avg)

0.84

Sales to Capital Employed (avg)

1.14

Tax Ratio

0.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

0.44%

ROE (avg)

1.93%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.41

EV to EBIT

277.93

EV to EBITDA

11.46

EV to Capital Employed

0.72

EV to Sales

0.62

PEG Ratio

Dividend Yield

ROCE (Latest)

0.26%

ROE (Latest)

-10.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET PROFIT(HY)

Higher at USD -22.42 MM

RAW MATERIAL COST(Y)

Fallen by -105.55% (YoY

EPS(Q)

Highest at USD -0.24

-35What is not working for the Company

NET PROFIT(HY)

At USD -22.42 MM has Grown at -41.28%

OPERATING CASH FLOW(Y)

Lowest at USD -36.18 MM

ROCE(HY)

Lowest at -13.63%

DEBT-EQUITY RATIO (HY)

Highest at 111.84 %

NET SALES(Q)

At USD 479.53 MM has Fallen at -22.83%

INTEREST COVERAGE RATIO(Q)

Lowest at 166.64

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.17 times

INTEREST(Q)

Highest at USD 16.48 MM

Here's what is working for Evolent Health, Inc.

Net Profit

Higher at USD -22.42 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS

Highest at USD -0.24

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by -105.55% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Evolent Health, Inc.

Net Profit

At USD -22.42 MM has Grown at -41.28%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Sales

At USD 479.53 MM has Fallen at -22.83%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Interest

At USD 16.48 MM has Grown at 42.01%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest Coverage Ratio

Lowest at 166.64

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at 111.84 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow

Lowest at USD -36.18 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Interest

Highest at USD 16.48 MM

in the last five periods and Increased by 42.01% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debtors Turnover Ratio

Lowest at 5.17 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio